Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy

Completed · Phase 2

Conditions studied: Ovarian Cancer, Primary Peritoneal Cavity Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of gemcitabine plus cisplatin in treating patients who have primary ovarian epithelial cancer or primary peritoneal cancer that is recurrent or has not responded to platinum-based chemotherapy.

Key facts

Study ID

NCT00006028

Run by

Gynecologic Oncology Group

Starts

2001-01-01

Last updated by the study team

2013-05-27

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Community Hospital of Los Gatos — Los Gatos, California, United States
• H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
• Rush-Presbyterian-St. Luke's Medical Center — Chicago, Illinois, United States
• University of Chicago Cancer Research Center — Chicago, Illinois, United States
• Indiana University Cancer Center — Indianapolis, Indiana, United States
• Ellis Fischel Cancer Center — Indianapolis, Indiana, United States
• Holden Comprehensive Cancer Center — Iowa City, Iowa, United States
• Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support — Bethesda, Maryland, United States
• Tuft-New England Medical Center — Boston, Massachusetts, United States
• University of Mississippi Medical Center — Jackson, Mississippi, United States
• Ellis Fischel Cancer Center - Columbia — Columbia, Missouri, United States
• Cooper Hospital/University Medical Center — Camden, New Jersey, United States
• State University of New York Health Science Center at Brooklyn — Brooklyn, New York, United States
• Roswell Park Cancer Institute — Buffalo, New York, United States
• State University of New York Health Sciences Center - Stony Brook — Stony Brook, New York, United States
• Lineberger Comprehensive Cancer Center, UNC — Chapel Hill, North Carolina, United States
• Duke Comprehensive Cancer Center — Durham, North Carolina, United States
• Comprehensive Cancer Center at Wake Forest University — Winston-Salem, North Carolina, United States
• Ireland Cancer Center — Cleveland, Ohio, United States
• Cleveland Clinic Taussig Cancer Center — Cleveland, Ohio, United States
• University of Oklahoma College of Medicine — Oklahoma City, Oklahoma, United States
• Abington Memorial Hospital — Abington, Pennsylvania, United States
• Milton S. Hershey Medical Center — Hershey, Pennsylvania, United States
• University of Pennsylvania Cancer Center — Philadelphia, Pennsylvania, United States
• Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.